William Dewey

Title: The Innovations of William Dewey

Introduction

William Dewey is an accomplished inventor based in Richmond, VA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of opioid-related treatments. With a total of 4 patents to his name, Dewey's work focuses on improving the efficacy and safety of opioid medications.

Latest Patents

Dewey's latest patents include groundbreaking innovations such as nanoparticle conjugated synthetic opioid prodrugs. These prodrugs are designed to target the peripheral mu opioid receptor (MOR) and exhibit long-lived bioavailability. They do not compromise the analgesic effects of opioids administered for pain relief and can even be used for pain management. Importantly, these prodrugs help prevent unwanted opioid-induced side effects, such as opioid-induced constipation (OIC). Another notable patent involves potent and selective mu opioid receptor modulators. These analogues of 6 α/β-naltrexamine (NAQ) serve as selective, reversible antagonists of the mu opioid receptor, demonstrating good blood-brain barrier penetration. They are utilized in the treatment of opioid addiction and other related conditions.

Career Highlights

William Dewey is affiliated with Virginia Commonwealth University, where he continues to advance his research and innovations. His work has garnered attention for its potential to transform the landscape of pain management and opioid addiction treatment.

Collaborations

Dewey collaborates with esteemed colleagues, including Yan Zhang and Dana E Selley, who contribute to his research endeavors.

Conclusion

William Dewey's innovative work in the field of opioid treatments showcases his commitment to improving patient outcomes. His patents reflect a deep understanding of the complexities surrounding opioid use and the need for safer alternatives.